Applied Nutrition on track but flags possible Middle East disruption

Applied Nutrition PLC on Monday left full-year guidance unchanged but cautioned events in the Middle East is disrupting logistics which is likely to prompt some loss of sales.

The Merseyside, England-based wellness brand said pretax profit soared 77% to £20.9 million in the half-year to January 31 from £11.8 million the year prior.

Basic and diluted earnings per share improved 77% to 6.2 pence from 3.5p.

Revenue increased 57% to £74.6 million from £47.6 million. For the full-year, Applied Nutrition retained its forecast for £140 million of revenue but cautioned events in the Middle East are likely to reduce volumes in the region.

In the financial year to July 2025, Applied Nutrition reported revenue of £107.1 million.

‘We are cognisant of the current disruption to shipping routes and purchasing activities within the region as well as the uncertainty around how long these conditions may persist,’ the firm said in a statement.

But it noted it has ‘managed similar disruption in the past,’ and was ‘working closely with customers to adapt our routes into the region and logistics arrangements to safeguard continued supply to those customers.’

In response, shares in Applied Nutrition slumped 11% to 196.80p each in London on Monday morning for a market capitalisation of around £476 million. The firm was valued at £350 million at its initial public offer in October 2024.

UK sales grew 46% to £31.5 million from £21.6 million a year ago, Europe sales increased 38% to £8.8 million from £6.4 million, International sales leapt 75% to £34.2 million from £19.6 million.

The FTSE 250 listing said that due to a better than expected peak trading period and accelerated demand for a number of first half product launches, revenue is likely to be weighted to the first six months of the financial year.

The company was included in the FTSE 250 in December, which it called a ‘significant milestone’.

Applied Nutrition said all half-year performance metrics were ahead of management expectations and consistent with the February trading update.

‘The performance and momentum across the business reflects a consumer environment that continues to shift decisively towards health, fitness and wellbeing,’ said Chief Executive Thomas Ryder.

Net cash at period end was £26.4 million, up from £10.9 million.

No dividend was declared and Applied Nutrition does not anticipate declaring a further dividend before financial 2027. The firm pointed out it did pay a dividend prior to its IPO.

Applied Nutrition noted construction has started on a global distribution facility and head office, and phase three of a factory extension which will increase revenue capability to £300 million.

Copyright 2026 Alliance News Ltd. All Rights Reserved.